BIOTRON LIMITED (BIT)

---

AI Coverage Rating: High

ASX AI Signals has generated 20 signals for BIT during the last 90 days, indicating strong trading activity and ongoing AI monitoring

Latest BIT Signals
18/06/2026	SELL
09/06/2026	SELL
08/06/2026	SELL
BIT Share Price
Current Price	$0.002
52 Week High	$0.005
52 Week Low:	$0.002
Trading at (% of 52 Week High)	40.00%

Business Overview

Biotron Limited (ASX: BIT) is an Australian biotechnology company that focuses on developing drugs to treat infectious diseases and immune-related disorders. The company is advancing therapies targeting conditions such as hepatitis B and COVID-19 through its proprietary drug candidates.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for BIOTRON LIMITED (BIT) is supported by the extremely low current price indicating potential distress or lack of market confidence. The AI signal aligns with technical and sentiment indicators suggesting downside risk. However, limited liquidity and potential volatility warrant caution.

Latest  BIOTRON LIMITED(BIT)   News